Skip to main content
Loading
Jennifer Fox - MaxCyte, Inc.

Jennifer Fox

Business Development Manager, MaxCyte, Inc.

Jennifer brings over 20 years of experience in Life Sciences and technical sales, with a strong background supporting biopharmaceutical manufacturing, gene editing, immuno-oncology, and research-driven organizations across North America. She has held senior commercial roles at industry leaders including Thermo Fisher Scientific, MaxCyte, EMD Millipore (now MilliporeSigma), and VWR International.
Jennifer earned her BA in Liberal Arts & Sciences from Sarah Lawrence College, and has continued her education with courses from the NIH in Genome Editing with CRISPR, and is currently an MS in Biotechnology at Northeastern University.
Jennifer rejoined MaxCyte in 2025 as the Business Development Manager for the northeastern US and eastern Canada.   She has oversight for the ExPERT series of electroporation instrumentation, as well as for our off target, risk-assessment assay services portfolio, SeQure.

Sessions